BGPT: Author Review: Naomi-Liza Denning

Explore by Goal

Low confidence. Please provide more context.

Quick Explanation Copied

Naomi-Liza Denning — evidence-limited author review
From the provided OpenAlex snapshot: 37 works, 1292 citations, h-index 12, with most citation mass concentrated in 2018–2020. This is consistent with a researcher who has published work that other scientists cite, but the snapshot alone doesn’t reveal study quality, methods rigor, or reproducibility.

Long Explanation

Author Review (Science-focused): Naomi-Liza Denning

Date context: March 30, 2026 • Evidence scope: only the OpenAlex snapshot provided in your prompt. No paper-level methods or findings were supplied, so I cannot assess biological claims, experimental rigor, or reproducibility from content.

1) Bibliometric indicators (from your provided OpenAlex snippet)

Works: 37
Citations: 1292
h-index: 12
ORCID: 0000-0001-6444-3845
Research topic cluster (as labeled by OpenAlex): Medicine (highest score), Surgery (high), Receptor / General surgery / Internal medicine (moderate)

Critical limitation: These metrics describe visibility and citation frequency, not whether the underlying biological work is correct, rigorous, or reproducible. High citation counts can reflect impact, but can also be influenced by field size, review articles, citation practices, and other non-quality factors.

2) Output + citation concentration by year

Raw values used exactly as provided: works_count and cited_by_count for years 2016, 2018, 2019, 2020, 2022, 2023, 2024, 2025.

3) “Impact concentration” check (citations vs. output)

Skeptical interpretation: This ratio is a rough proxy and can be distorted by field timing, indexing delays, and the fact that older papers accumulate more citations. It is not a measure of experimental quality.

4) Topic signal (from OpenAlex labels)

Topic scores shown exactly as provided by your OpenAlex snippet.

5) Scientific strength review — what I can and cannot conclude

What the snapshot supports (weak→moderate evidence):

Community attention: 1292 citations and h-index 12 suggest the author’s work is repeatedly cited by others (but does not prove correctness).
Active publication era: output peaks in 2020 (17 works) within the provided window; citation counts also peak strongly in 2019 (688).

What the snapshot cannot establish (major gap):

Methodological rigor: Without paper-level protocols, sample sizes, controls, blinding, statistical analysis, or effect sizes, I cannot assess rigor.
Reproducibility: No information is provided about replication studies, pre-registration, data/code availability, or raw data access.
Biological validity: No experimental findings are provided, so I cannot judge biological plausibility, mechanistic coherence, or whether claims were later revised.
Potential bias: Citation metrics can be inflated by review/consensus dynamics and underestimated fields; without content-level evaluation, quality remains unknown.

How I would evaluate scientific strength next (needs paper-level data):

Identify the top cited works and inspect whether they use robust experimental designs, appropriate controls, and transparent statistics.
Check whether later work confirms/refutes key mechanistic claims and whether data were shared.
Assess whether the author’s contribution appears first-author/methodologically central versus being a collaborator in large studies.
Look for red flags: selective reporting, outcome switching, weak blinding, p-hacking risks, or results that were later contradicted.

6) Actionable BGPT follow-ups (optional)

If you want a true scientific author review (methods, evidence strength, reproducibility), you’ll need paper-level inputs. Here are targeted next queries.

Feedback:

Updated: March 30, 2026